EU medtech reg text still needs more change, says MEPs
This article was originally published in Clinica
Peter Liese and Mairead McGuinness, MEPs from the European People’s Party Group, have warned that further changes are needed to the proposed new EU regulation on medical devices, following the 25 September vote by ENVI, the European Parliament's committee for the environment, public health and food safety to carry through all 28 compromise amendments made to the text (www.clinica.co.uk, 25 September 2013).
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.